Occam Recruits CEO for Khosla, GV, and Third Rock Investment EveryOne Medicines

Occam Recruits CEO for Khosla, GV, and Third Rock Investment EveryOne Medicines

In June 2024, Occam Global recruited Kent Rogers as CEO of EveryONE Medicinesthe first biotech solely dedicated to developing personalized genetic medicines.  


Kent is an accomplished executive with over 30 years of experience in product commercialization, supply chain logistics, and growth strategy across top-tier pharmaceutical firms and emerging biotechs. Previously, he served as the Chief Industry Relations Officer for OptumRx, led the global market access team at Acorda Therapeutics, and held various leadership roles in sales and market access at Schering-Plough and Merck. 


Kent holds a B.S. in Business Management from Indiana University and an M.B.A. from Emory University’s Goizueta School of Business.





Backed by Khosla Ventures, GV, and Third Rock Ventures, EveryONE Medicines (EOM) is dedicated to rapidly and efficiently advancing medicines for uniquely rare CNS disorders. With a foundation set for commercial success and growing legislative support, including a central role in a UK pilot program for individualized medicines – the Rare Therapies Launch Pad, the company’s mission is to develop a new sustainable and scalable pathway for individualized genetic medicines. For more information, visit


Occam Global is a leading international executive recruiter for biotechnology, having completed several of the most challenging and specialized executive search requirements across the life sciences. The firm’s distinct competence lies in a proven ability to attract exceptional business and scientific leaders, fluid access to uncommon talent, and an enduring commitment to results informed by elevated ethics and enlightened aggression. As a result, Occam has established itself asa trusted search partner for entrepreneurs, investors, and corporations globally. Our success is rooted in cultivating and valuing relationships, establishing trust with entrepreneurs, executives, and investors, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions. Contact Occam Global today for your biotech executive recruiting needs.

About Occam Global

Occam Global is an executive recruiting and leadership advisory firm with specialties across technological fields including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.